Loss of Rnf31 and Vps4b sensitizes pancreatic cancer to T cell-mediated killing
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Loss of Rnf31 and Vps4b sensitizes pancreatic cancer to T cell-mediated killing
Authors
Keywords
-
Journal
Nature Communications
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-04-04
DOI
10.1038/s41467-022-29412-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In vivo screens using a selective CRISPR antigen removal lentiviral vector system reveal immune dependencies in renal cell carcinoma
- (2021) Juan Dubrot et al. IMMUNITY
- HOIP limits anti‐tumor immunity by protecting against combined TNF and IFN‐gamma‐induced apoptosis
- (2021) Andrew J Freeman et al. EMBO REPORTS
- Regulatory T-cell Depletion Alters the Tumor Microenvironment and Accelerates Pancreatic Carcinogenesis
- (2020) Yaqing Zhang et al. Cancer Discovery
- Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer
- (2020) Samarth Hegde et al. CANCER CELL
- Linear Ubiquitin Code: Its Writer, Erasers, Decoders, Inhibitors, and Implications in Disorders
- (2020) Daisuke Oikawa et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A genome-scale CRISPR screen identifies the ERBB and mTOR signalling networks as key determinants of response to PI3K inhibition in pancreatic cancer
- (2020) Charlotte K Milton et al. MOLECULAR CANCER THERAPEUTICS
- Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I
- (2020) Keisuke Yamamoto et al. NATURE
- Pancreatic cancer stroma: an update on therapeutic targeting strategies
- (2020) Abdel N. Hosein et al. Nature Reviews Gastroenterology & Hepatology
- Global Regulation of the Histone Mark H3K36me2 Underlies Epithelial Plasticity and Metastatic Progression
- (2020) Salina Yuan et al. Cancer Discovery
- CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond
- (2020) Nathan Karin Frontiers in Immunology
- Inhibition of Vps34 reprograms cold into hot inflamed tumors and improves anti–PD-1/PD-L1 immunotherapy
- (2020) Muhammad Zaeem Noman et al. Science Advances
- Targeting the Microenvironment to Overcome Gemcitabine Resistance in Pancreatic Cancer
- (2020) Eileen S. Carpenter et al. CANCER RESEARCH
- Functional genomic landscape of cancer-intrinsic evasion of killing by T cells
- (2020) Keith A. Lawson et al. NATURE
- Functional Genomics Identifies Metabolic Vulnerabilities in Pancreatic Cancer
- (2020) Douglas E. Biancur et al. Cell Metabolism
- c-FLIP and CD95 signaling are essential for survival of renal cell carcinoma
- (2019) Tobias Luebke et al. Cell Death & Disease
- Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold
- (2019) David W. Vredevoogd et al. CELL
- Systematic Immunotherapy Target Discovery Using Genome-Scale In Vivo CRISPR Screens in CD8 T Cells
- (2019) Matthew B. Dong et al. CELL
- The pharmalogical reactivation of p53 function improves breast tumor cell lysis by granzyme B and NK cells through induction of autophagy
- (2019) Marie Chollat-Namy et al. Cell Death & Disease
- Down Regulation of c-FLIPL Enhance PD-1 Blockade Efficacy in B16 Melanoma
- (2019) Yao Wang et al. Frontiers in Oncology
- In vivo epigenetic CRISPR screen identifies Asf1a as an immunotherapeutic target in Kras-mutant lung adenocarcinoma
- (2019) Fei Li et al. Cancer Discovery
- CXCL9/10/11, a regulator of PD-L1 expression in gastric cancer
- (2018) Chenlu Zhang et al. BMC CANCER
- A major chromatin regulator determines resistance of tumor cells to T cell–mediated killing
- (2018) Deng Pan et al. SCIENCE
- Structural absorption by barbule microstructures of super black bird of paradise feathers
- (2018) Dakota E. McCoy et al. Nature Communications
- Epithelial-Stromal Interactions in Pancreatic Cancer
- (2018) Yaqing Zhang et al. Annual Review of Physiology
- Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function
- (2018) Eric Shifrut et al. CELL
- Linear ubiquitination of cFLIP induced by LUBAC contributes to TNFα-induced apoptosis
- (2018) Yong Tang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade
- (2018) Jeffrey J. Ishizuka et al. NATURE
- PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity
- (2017) Vikram R. Juneja et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The Met1-Linked Ubiquitin Machinery: Emerging Themes of (De)regulation
- (2017) Matous Hrdinka et al. MOLECULAR CELL
- Identification of essential genes for cancer immunotherapy
- (2017) Shashank J. Patel et al. NATURE
- In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
- (2017) Robert T. Manguso et al. NATURE
- Tumor Mutational Burden and Response Rate to PD-1 Inhibition
- (2017) Mark Yarchoan et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Autophagic Flux Probe that Releases an Internal Control
- (2016) Takeshi Kaizuka et al. MOLECULAR CELL
- Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
- (2016) John G Doench et al. NATURE BIOTECHNOLOGY
- Organoid Models of Human and Mouse Ductal Pancreatic Cancer
- (2015) Sylvia F. Boj et al. CELL
- Granzyme B degradation by autophagy decreases tumor cell susceptibility to natural killer-mediated lysis under hypoxia
- (2013) J. Baginska et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma
- (2010) Richard E. Royal et al. JOURNAL OF IMMUNOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started